Published on Frontotemporal Dementia (FTD) (http://memory.ucsf.edu/ftd)

Home > Measuring Attention & Executive Function

By admin
Created 11/25/2008 - 02:21

Measuring Attention & Executive Function

Attention and Executive Functioning in Frontotemporal Dementia

Summary

  • Study director: Joel Kramer, PsyD [1]
  • Sponsor: National Institutes of Health (NIH)
  • Recruiting?: Yes
  • Official study title: Attention and Executive Functioning in Frontotemporal Dementia
  • Conditions studied: Frontotemporal dementia (FTD) [2], Alzheimer's disease (AD) [3], mild cognitive impairment (MCI) [4], semantic dementia (SD) [2] and healthy adults [5] (NC or "normal control")
  • Purpose: To determine differences in and underlying brain regions responsible for attention.

Eligibility

  • Inclusion criteria: Subjects must be between the ages of 45-95, have a neurodegenerative disorder or be a healthy, age-matched normal control, have a Mini Mental State Examination (MMSE) score of 20 or greater and a Geriatric Depression Scale (GDS) score less than 20.
  • Exclusion criteria: Previous history of Korsakoff encephalopathy, alcohol abuse or dependence within 5 years of onset of dementia, substance abuse, head trauma with loss of consciousness greater than 30 minutes, brain tumor, multiple sclerosis, epilepsy, hydrocephalus, schizophrenia, bipolar affective disorder, intracerebral hemorrhage, current history of pacemaker, ferromagnetic material in soft tissue, B12 deficiency, hypothyroidism (TSH>150% of normal), known HIV, renal failure, respiratory failure requiring oxygen, history of major depression within the past 2 years, Geriatric Depression Scale (GDS) score greater than 20, anxiety disorder due to other than dementia and requiring medication more than 3x per week, cerebral infarct, large confluent white matter lesions or grade 4 white matter lesions as described by Schletens et al., significant systematic medical illnesses such as deteriorating cardiovascular disease, clinically relevant EKG changes, current medication likely to affect central nervous system (CNS) functions.

What is involved?

  • Testing: Computer-based tests measuring attention and reaction time, total time approximately 1 hour.
  • Frequency of visits: 1 visit
  • Materials needed prior to evaluation: None
  • Costs: No costs will be charged for any of the study procedures.

Contact information

  • Coordinator: 415-476-1680
  • Clinical Research
© 2012 The Regents of the University of California

Source URL: http://memory.ucsf.edu/ftd/research/clinical/attention

Links:
[1] http://memory.ucsf.edu/ftd/staff/jkramer
[2] http://memory.ucsf.edu/ftd/overview/forms/multiple
[3] http://memory.ucsf.edu/Education/Disease/ad.html
[4] http://memory.ucsf.edu/Education/Disease/mci.html
[5] http://memory.ucsf.edu/Education/Topics/normalaging.html